Insight Molecular Diagnostics Inc.
NASDAQIMDX short interest surges 57% in one week to 3.0% of float as stock rallies 61% in May.
Snapshot as of 28 Jun 2026
Insight Molecular Diagnostics heads into the aftermath of its Q1 earnings print with a rare convergence: short interest more than doubling in a month, options tilting to the most defensive reading in a year, and a…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IMDX — free to start on ORTEX.
Sign up for free →Open IMDX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live IMDX data →